Jeung-Sik Lee

Title: Jeung-Sik Lee: Innovator in Blood Coagulation Research

Introduction

Jeung-Sik Lee is a notable inventor based in Kyoungki-do, South Korea. He has made significant contributions to the field of blood coagulation research. His innovative work has led to the development of a unique method for determining the enzymatic activity of blood coagulation factor XIII.

Latest Patents

Jeung-Sik Lee holds a patent for a method titled "Method of determining the enzymatic activity of the blood coagulation factor XIII using purified fibrin monomer as a substrate." This invention relates to a method that utilizes purified fibrin monomer as a substrate to assess the enzymatic activity of blood coagulation factor XIII. The process involves detecting the degree of cross-linking of fibrin monomer formed by the enzyme, with the fibrin monomer free of blood coagulation factor XIII obtained through washing with citric acid solution. This method is valuable for validating other enzymatic assay methods for blood coagulation factor XIII and for characterizing the enzyme itself.

Career Highlights

Jeung-Sik Lee is currently associated with Korea Greencross Corporation, where he continues to advance his research in blood coagulation. His work has been instrumental in enhancing the understanding of blood coagulation mechanisms and improving diagnostic methods.

Collaborations

He has collaborated with notable colleagues, including Jae-Wook Huh and Shin-Jae Chang, contributing to various research projects and innovations in the field.

Conclusion

Jeung-Sik Lee's contributions to blood coagulation research through his innovative patent demonstrate his commitment to advancing medical science. His work not only enhances our understanding of blood coagulation but also paves the way for improved diagnostic techniques.